Venus Concept Inc., a publicly traded medical aesthetic technology company listed on the NASDAQ under the ticker VERO, witnessed a remarkable increase in its stock price on Friday, with shares climbing over 500% during intraday trading. This sharp upward movement places VERO among the top-performing stocks on that day, capturing attention from market participants and analysts alike.
A notable factor underpinning this surge was the announcement from Madryn Asset Management, an alternative asset management firm, which revealed it had acquired a 91% ownership stake in Venus Concept. This disclosure was made public through a Securities and Exchange Commission (SEC) filing on Friday, marking a significant milestone for the company’s shareholder structure.
Madryn Asset Management indicated that its investment in Venus Concept is for strategic purposes. As a controlling stakeholder, Madryn expressed intentions to play an active role in guiding the company’s operational, financial, and strategic directions. Particularly, the asset manager plans to collaborate closely with Venus Concept regarding the evaluation of potential strategic alternatives to optimize shareholder value.
According to Madryn Asset Management's official website, the firm specializes in investments in innovative healthcare companies that focus on transformative products, technologies, and services. This aligns with Venus Concept’s positioning within the medical aesthetic technology sector.
The sizable stake acquisition by Madryn followed a prior financial arrangement whereby the asset management firm exchanged $11.48 million worth of subordinated convertible notes for 545,335 shares of Venus Concept’s Series Y preferred stock in October 2025, further consolidating its interest in the company.
Investor interest in Venus Concept was also reflected in the extraordinary trading volume on Friday. The stock traded over 223 million shares, a staggering figure compared to its average daily volume of approximately 1.74 million shares, showcasing heightened market activity and liquidity.
Despite the recent bullish momentum in the stock price, Venus Concept’s latest financial results presented some headwinds. The company’s earnings report for the third quarter indicated revenues of $13.78 million, falling short of the consensus estimate of $14.48 million. This equates to an 8% decrease in sales year-over-year and a 12% decline from the previous quarter.
The decrease in revenue was primarily attributed to a downturn in the Hair Restoration segment, which experienced setbacks due to delays related to a pending sale. This segment’s struggles weighed on overall company performance for the period.
On the innovation front, Venus Concept made meaningful strides in November 2025, securing 510(k) clearance from the United States Food and Drug Administration (FDA) for its Venus NOVA platform. This next-generation device represents a multi-application system designed to revolutionize non-invasive treatments across body, face, and skin care categories.
The Venus NOVA system integrates several proprietary technologies. It employs Adaptive Electrical Muscle Stimulation (EMS) alongside Multi-Polar Radio Frequency (RF), Pulsed Electromagnetic Fields (PEMF), and Advanced VariPulse technology. Together, these modalities aim to offer comprehensive solutions for applications such as body contouring, muscle conditioning, skin treatments, wrinkle reduction, and cellulite management.
As of the close of trading on Friday, Venus Concept shares were priced at $9.91, a 593.01% increase relative to the prior session's close. This price action reflects the market’s strong reaction to both the ownership developments and the company’s recent regulatory and product updates.
While the surge is significant, it is important to consider the operational challenges highlighted in the company’s recent financials. The mixed performance underscores the complexities Venus Concept faces in achieving consistent growth amid the evolving medical aesthetics landscape.
Moving forward, the active involvement of Madryn Asset Management as a controlling shareholder could steer strategic initiatives and financial restructuring that may impact Venus Concept’s trajectory. Investors are keenly observing how this partnership will unfold and influence the company’s competitive positioning and long-term value creation.